Strados Labs Announces Pediatric Asthma Study to Validate its Wearable Device in Children with Wheeze
Strados Labs’ RESP™ Biosensor is currently being used in a clinical trial at Lurie Children’s to determine if it can accurately detect wheezing in children. Labs PHILADELPHIA, PA, UNITED STATES, September 26, 2023 /EINPresswire.com/ — Strados Labs has partnered with Ann & Robert... Read More →
Surgery Center is First in Southern California to Adopt New Wireless Technology for Arthroscopy featuring Lazurite
De La Vina Surgicenter in Santa Barbara, CA, and medical device and technology company Lazurite® announced that De La Vina is the first healthcare center in Southern California to adopt Lazurite’s new ArthroFree® Wireless Surgical Camera System. De La Vina has used... Read More →
GI health platform Vivante Health secures $31M
The company offers personalized care plans and connects patients with a coordinated care team, including dietitians, internists and gastroenterologists. Digital gastrointestinal health company Vivante Health announced it closed a $31 million Series B funding round led by new investor Mercato... Read More →
Day Zero Diagnostics Announces Completion of $16M Financing Round
BOSTON, Sept. 20, 2023 /PRNewswire/ — Day Zero Diagnostics Inc. (DZD), an infectious disease diagnostics company harnessing the power of whole-genome sequencing and AI to combat the rise of antibiotic-resistant infections, announced today the recent completion of a $16M round... Read More →
Tasso Receives CE Mark Certification for Tasso+™, Latest Generation Whole Blood Collection Lancet Device
SEATTLE–(BUSINESS WIRE)–Tasso, Inc., the leading provider of patient-centric clinical-grade blood collection solutions, today announced it received CE Mark certification for its Tasso+™ device, a convenient, virtually pain-free blood lancet that collects whole liquid blood samples. The CE Mark designation allows... Read More →
InBrain Neuroelectronics wins FDA breakthrough nod for intelligent network modulation system
InBrain Neuroelectronics announced today that it received FDA breakthrough device designation for its intelligent network modulation system. The breakthrough nod covers the graphene-neural platform as an adjunctive therapy for treating Parkinson’s disease. Read More
CardiaCare Completes Seed Extension Raise to Support Clinical Pilot Studies
REHOVOT, Israel, Sept. 18, 2023 /PRNewswire/ — CardiaCare, a medical device company developing a breakthrough wearable technology for detecting, monitoring, and non-invasively treating cardiac arrhythmias using drug-free neuromodulation, recently closed an over-subscribed Seed Extension round. The financing was led by... Read More →
Conavi Medical Announces Close of Financing to Bolster Novel Intravascular Imaging Technology
TORONTO, CA, September 18, 2023 – Conavi Medical, Inc. (www.conavi.com), a leader in hybrid intravascular imaging, is pleased to announce the close of $12.5 mil USD of funding, including participation from existing investors. The round was led by CPOINT Capital,... Read More →
SpineGuide Technologies Receives U.S. FDA Breakthrough Device Designation for CurvRITE System in Treating Patients with EOS
St Paul, Minnesota, September 11, 2023 —- SpineGuide Technologies, a global medical device company, has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its CurvRITE System to treat Children with Early Onset Scoliosis (EOS). The... Read More →
FDA Approves Blood Flow-Diverting LimFlow System for No-Option CLTI
The basis for the approval was the successful results for deep-vein arterialization borne out in the PROMISE II trial. The US Food and Drug Administration has approved the LimFlow self-expanding covered stent system for arterialization of deep veins in the... Read More →